Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JPMHC 2021
JPMHC 2021
J.P. Morgan: Will Biotech’s Virtual 2021 Launch Become the New Reality?
J.P. Morgan: Will Biotech’s Virtual 2021 Launch Become the New Reality?
BioSpace
virtual meetings
biotech
JPMHC 2021
Flag link:
JPM: 'Stick a fork in it'—J.P. Morgan in San Francisco is done, reader poll results say
JPM: 'Stick a fork in it'—J.P. Morgan in San Francisco is done, reader poll results say
Fierce Pharma
JPMHC
JPMHC 2021
virtual meetings
pandemic
Flag link:
Final Highlights from the 2021 J.P. Morgan Healthcare Conference
Final Highlights from the 2021 J.P. Morgan Healthcare Conference
BioSpace
JPMHC 2021
intravenous immunoglobulin
IDEAYA Biosciences
Jounce Therapeutics
Puma Biotechnology
Flag link:
JPM: Established relationships were key to pandemic drug launches, Incyte CEO says
JPM: Established relationships were key to pandemic drug launches, Incyte CEO says
Fierce Pharma
COVID-19
pandemic
drug launches
Incyte
JPMHC 2021
Flag link:
Intuitive, J&J, Medtronic and Zimmer talk robotic surgery ambitions: JPM21
Intuitive, J&J, Medtronic and Zimmer talk robotic surgery ambitions: JPM21
Medtech Dive
JPMHC 2021
robotic surgery
devices
Intuitive Surgical
JNJ
Medtronic
Zimmer Biomet
Flag link:
JPM: Jazz eyes a 'dramatic' shift to new-drug revenue by 2022, CEO says
JPM: Jazz eyes a 'dramatic' shift to new-drug revenue by 2022, CEO says
Fierce Pharma
Jazz Pharmaceuticals
JPMHC 2021
Flag link:
#JPM21: Avidity CSO Art Levin runs full speed to the clinic with 'dream' antibody oligonucleotide conjugate therapy
#JPM21: Avidity CSO Art Levin runs full speed to the clinic with 'dream' antibody oligonucleotide conjugate therapy
Endpoints
Avidity
JPMHC 2021
oligonucleotide-based therapies
muscle diseases
Flag link:
JPM: How did Pfizer up its COVID-19 vaccine capacity? 'Out of the box manufacturing,' CEO says
JPM: How did Pfizer up its COVID-19 vaccine capacity? 'Out of the box manufacturing,' CEO says
Fierce Pharma
Pfizer
BioNTech
vaccines
COVID-19
JPMHC 2021
drug manufacturing
Albert Bourla
Flag link:
JPM: Sanofi's new chief digital officer steps up ambitions in marketing, research and even e-commerce
JPM: Sanofi's new chief digital officer steps up ambitions in marketing, research and even e-commerce
Fierce Pharma
JPMHC 2021
Sanofi
digital pharma
Flag link:
JPM: CureVac's new pharma partner Bayer says its COVID-19 vaccine not just an also-ran
JPM: CureVac's new pharma partner Bayer says its COVID-19 vaccine not just an also-ran
Fierce Biotech
CureVac
Bayer
vaccines
COVID-19
JPMHC 2021
Flag link:
A longtime Pfizer chief's ultra-quiet biotech re-emerges with new cash and plans for the clinic
A longtime Pfizer chief's ultra-quiet biotech re-emerges with new cash and plans for the clinic
Endpoints
Elucida Oncology
Pfizer
JPMHC 2021
Flag link:
JPM: Lilly, Moderna, insitro CEOs say pandemic forced R&D, marketing and ops changes worth keeping
JPM: Lilly, Moderna, insitro CEOs say pandemic forced R&D, marketing and ops changes worth keeping
Fierce Pharma
JPMHC 2021
COVID-19
pandemic
R&D
drug marketing
David Ricks
Stephane Bancel
Pharma CEOs
Flag link:
JPM21: Vaccines soar, antibodies struggle as COVID-19 drugs become a business
JPM21: Vaccines soar, antibodies struggle as COVID-19 drugs become a business
BioPharma Dive
JPMHC 2021
pandemic
COVID-19
Flag link:
JPM Week: Will the first COVID-19 vaccines deter future launches? Not at all, experts say
JPM Week: Will the first COVID-19 vaccines deter future launches? Not at all, experts say
Fierce Pharma
vaccines
pandemic
COVID-19
JPMHC 2021
Flag link:
JPM: Verve Therapeutics unveils its lead program—a one-and-done treatment for genetic high cholesterol
JPM: Verve Therapeutics unveils its lead program—a one-and-done treatment for genetic high cholesterol
Fierce Biotech
JPMHC 2021
Verve Therapeutics
VERVE-101
familial hypercholesterolemia
Flag link:
Key takeaways from BioNTech CEO’s JPM presentation
Key takeaways from BioNTech CEO’s JPM presentation
MedCity News
JPMHC 2021
BioNTech
vaccines
COVID-19
MRNA
Flag link:
JPM: Novartis CMO Tsai on how the pandemic is changing the face of biopharma R&D, how pharma works
JPM: Novartis CMO Tsai on how the pandemic is changing the face of biopharma R&D, how pharma works
Fierce Biotech
JPMHC 2021
pandemic
Novartis
COVID-19
R&D
Flag link:
JPM: Boehringer inks Enara deal to source 'dark antigens' for cancer immunotherapies
JPM: Boehringer inks Enara deal to source 'dark antigens' for cancer immunotherapies
Fierce Biotech
JPMHC 2021
Boehringer Ingelheim
Enara Bio
dark antigens
cancer
cancer vaccines
Flag link:
JPM: 'Very soon,' says Johnson & Johnson CEO as world waits for its COVID-19 vaccine data
JPM: 'Very soon,' says Johnson & Johnson CEO as world waits for its COVID-19 vaccine data
Fierce Pharma
JNJ
JPMHC 2021
vaccines
COVID-19
clinical trials
Flag link:
JPM21: Biogen faces make-or-break year, Vertex mulls deals and Sarepta pitches a silver lining
JPM21: Biogen faces make-or-break year, Vertex mulls deals and Sarepta pitches a silver lining
BioPharma Dive
JPMHC 2021
Biogen
Vertex Pharmaceuticals
Sarepta Therapeutics
Flag link:
Pages
1
2
next ›
last »